(Q35009459)

English

Netazepide, a gastrin receptor antagonist, normalises tumour biomarkers and causes regression of type 1 gastric neuroendocrine tumours in a nonrandomised trial of patients with chronic atrophic gastritis

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

Netazepide, a gastrin receptor antagonist, normalises tumour biomarkers and causes regression of type 1 gastric neuroendocrine tumours in a nonrandomised trial of patients with chronic atrophic gastritis (English)

1 reference

Europe PubMed Central

5 August 2017

0 references

6

object named as

D Mark Pritchard

1 reference

Europe PubMed Central

5 August 2017

object named as

Malcolm Boyce

2

0 references

author name string

Andrew R Moore

1

1 reference

Europe PubMed Central

5 August 2017

Islay A Steele

3

1 reference

Europe PubMed Central

5 August 2017

Fiona Campbell

4

1 reference

Europe PubMed Central

5 August 2017

Andrea Varro

5

1 reference

Europe PubMed Central

5 August 2017

language of work or name

0 references

publication date

1 October 2013

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

8

1 reference

Europe PubMed Central

5 August 2017

10

1 reference

Europe PubMed Central

5 August 2017

e76462

1 reference

Europe PubMed Central

5 August 2017

copyright license

Creative Commons Attribution 4.0 International

1 October 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

Netazepide, a gastrin/CCK2 receptor antagonist, causes dose-dependent, persistent inhibition of the responses to pentagastrin in healthy subjects.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

Effect of repeated doses of netazepide, a gastrin receptor antagonist, omeprazole and placebo on 24 h gastric acidity and gastrin in healthy subjects

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

Pitfalls in diagnostic gastrin measurements

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

Gastrin stimulates expression of plasminogen activator inhibitor-1 in gastric epithelial cells.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

Laparoscopic antrectomy for the treatment of type I gastric carcinoid tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

En-bloc resection of multiple type 1 gastric carcinoid tumors by endoscopic multi-band mucosectomy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

Increased expression of the urokinase plasminogen activator system by Helicobacter pylori in gastric epithelial cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

Role of CCK/gastrin receptors in gastrointestinal/metabolic diseases and results of human studies using gastrin/CCK receptor agonists/antagonists in these diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

Increased gastric expression of MMP-7 in hypergastrinemia and significance for epithelial-mesenchymal signaling.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

Review article: Pathogenesis and management of gastric carcinoid tumours.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

Presentation, treatment, and outcome of type 1 gastric carcinoid tumors

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

Gastric carcinoids: a temporal increase with proton pump introduction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

Dipyridamole bioavailability in subjects with reduced gastric acidity

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

Guidelines for the diagnosis and treatment of neuroendocrine gastrointestinal tumours. A consensus statement on behalf of the European Neuroendocrine Tumour Society (ENETS).

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

Endoscopic resection with a two-channel videoendoscope for gastric carcinoid tumors.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

Gastrin: an analytical review

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

Cholecystokinin antagonists: pharmacological and therapeutic potential

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

Gastrin agonists and antagonists

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

Identification of plasminogen activator inhibitor-2 as a gastrin-regulated gene: Role of Rho GTPase and menin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

Validation of a liquid chromatographic-tandem mass spectrometric method for the measurement of (R)-1-[2,3-dihydro-2-oxo-1-pivaloylmethyl-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl]-3-(3-methylaminophenyl)urea (YF476) in human plasma

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

The gastrins: their production and biological activities

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

Effects of YF476, a potent and selective gastrin/cholecystokinin-B receptor antagonist, on gastric acid secretion in beagle dogs with gastric fistula.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

YF476 is a new potent and selective gastrin/cholecystokinin-B receptor antagonist in vitro and in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

(3R)-N-(1-(tert-butylcarbonylmethyl)-2,3-dihydro-2-oxo-5-(2-pyridyl)-1H-1,4-benzodiazepin-3-yl)-N'-(3-(methylamino)phenyl)urea (YF476): a potent and orally active gastrin/CCK-B antagonist

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

Antrectomy for multicentric, argyrophil gastric carcinoids: a preliminary report.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

Histopathological classification of nonantral gastric endocrine growths in man.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

Gastrointestinal side-effects of octreotide during long-term treatment of acromegaly

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

8 July 2018

Type I gastric carcinoids: a prospective study on endoscopic management and recurrence rate

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0076462

21 January 2018

Treatment of ECL cell carcinoids with octreotide LAR.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0076462

21 January 2018

Treatment of type I gastric neuroendocrine tumors with somatostatin analogs

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0076462

21 January 2018

Long-acting somatostatin analogues are an effective treatment for type 1 gastric carcinoid tumours.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0076462

21 January 2018

Gastric endocrine tumors type I: treatment with long-acting somatostatin analogs

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0076462

21 January 2018

Serum chromogranin A as a screening test for gastric enterochromaffin-like cell hyperplasia during acid-suppressive therapy.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0076462

21 January 2018

A meal test improves the specificity of chromogranin A as a marker of neuroendocrine neoplasia

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0076462

21 January 2018

Long-lasting cholecystokinin(2) receptor blockade after a single subcutaneous injection of YF476 or YM022.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0076462

21 January 2018

Spontaneous ECL cell carcinomas in cotton rats: natural course and prevention by a gastrin receptor antagonist.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0076462

21 January 2018

The CCK(2) receptor antagonist, YF476, inhibits Mastomys ECL cell hyperplasia and gastric carcinoid tumor development

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0076462

21 January 2018

Synergistic inhibitory effects of gastrin and histamine receptor antagonists on Helicobacter-induced gastric cancer.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0076462

21 January 2018

Single oral doses of netazepide (YF476), a gastrin receptor antagonist, cause dose-dependent, sustained increases in gastric pH compared with placebo and ranitidine in healthy subjects.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0076462

21 January 2018

Treatment of gastric carcinoids type 1 with the gastrin receptor antagonist netazepide (YF476) results in regression of tumours and normalisation of serum chromogranin A.

1 reference

https://api.crossref.org/works/10.1371%2FJOURNAL.PONE.0076462

21 January 2018

Chromogranin A: is it a useful marker of neuroendocrine tumors?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3788129

26 October 2018

Short report: the absorption of fluconazole and itraconazole under conditions of low intragastric acidity

1 reference

https://pubmed.ncbi.nlm.nih.gov/24098507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Octreotide suppression test predicts beneficial outcome from antrectomy in a patient with gastric carcinoid tumor

1 reference

https://pubmed.ncbi.nlm.nih.gov/24098507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Plasma chromogranin A in patients with autoimmune chronic atrophic gastritis, enterochromaffin-like cell lesions and gastric carcinoids

1 reference

https://pubmed.ncbi.nlm.nih.gov/24098507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastric carcinoids: biologic behavior and prognosis after differentiated treatment in relation to type

1 reference

https://pubmed.ncbi.nlm.nih.gov/24098507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Gastrin-induced apoptosis contributes to carcinogenesis in the stomach

1 reference

https://pubmed.ncbi.nlm.nih.gov/24098507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Usefulness of laparoscope-assisted antrectomy for gastric carcinoids with hypergastrinemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24098507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Zollinger-Ellison syndrome and mismeasurement of gastrin

1 reference

https://pubmed.ncbi.nlm.nih.gov/24098507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

ENETS 2011 Consensus Guidelines for the Management of Patients with Digestive Neuroendocrine Tumors: An Update

1 reference

https://pubmed.ncbi.nlm.nih.gov/24098507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Correlation between a short-term intravenous octreotide suppression test and response to antrectomy in patients with type-1 gastric neuroendocrine tumours

1 reference

https://pubmed.ncbi.nlm.nih.gov/24098507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunochemical studies on big gastrin using NH2-terminal specific antisera

1 reference

https://pubmed.ncbi.nlm.nih.gov/24098507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Rapid regression of enterochromaffinlike cell gastric carcinoids in pernicious anemia after antrectomy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24098507

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1371/JOURNAL.PONE.0076462

1 reference

Europe PubMed Central

5 August 2017

2013PLoSO...876462M

0 references

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35009459&oldid=1863888979"